Diapositivas sobre el antenimiento de la atención del VIH durante la pandemia de COVID-19 en México

Diapositivas de expertos-autores sobre la colisión de VIH y COVID-19 en México, incluyendo, el impacto del VIH en la prevalencia y la gravedad de la enfermedad de COVID-19, el impacto de la COVID-19 en la atención al VIH en México, y las estrategias e intervenciones para mitigar el impacto de la COVID-19 en la atención del VIH.
Luis E. Soto-Ramirez, MD
Program Director
person default
Luis G. García Demuner, MD
Samuel Navarro, MD
Leticia M. Pérez Saleme, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.81 MB
Released: December 10, 2020

Acknowledgements

Este programa cuenta con una subvención educativa de
ViiV Healthcare

Related Content

Short video log from Rajesh Gandhi, MD, on the efficacy and safety of COVID-19 vaccines in older persons and persons with HIV

Rajesh T. Gandhi, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 21, 2021 Expired: January 20, 2022

Free expert-authored slides reviewing a patient case and the data on efficacy and safety of authorized COVID-19 vaccines in older persons with HIV

Rajesh T. Gandhi, MD Released: January 21, 2021

Short video log from Rajesh Gandhi, MD, on COVID-19 risk in older persons with HIV and implications for COVID-19 vaccine recommendation

Rajesh T. Gandhi, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 20, 2021 Expired: January 19, 2022

Free expert-authored slides reviewing a patient case and the data on COVID-19 risk in persons with HIV that may inform vaccine prioritization

Rajesh T. Gandhi, MD Released: January 20, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue